Today Jun 27 First Trust NYSE Arca Biotech ETF (FBT) Increases 0.04%

June 27, 2018 - By Samuel McNeil

First Trust NYSE Arca Biotech ETF (NYSEARCA:FBT) has positive Jun 27 day. The ETF reached $140.68 per share after 0.04% change. It has 1.55 billion net assets and 1.68% volatility for the month.

Till now 6,840 shares traded hands. The avg volume is 65,570 over the last month for First Trust NYSE Arca Biotech ETF (NYSEARCA:FBT).

The ATR of ETF is 2.6, that’s -5.52% of its 52-Week High and 35.02% of its 52-Week Low. The current year and quarter efficiency are: 11.57% and 4.54%.

First Trust NYSE Arca Biotech ETF has perf of 12.35% YTD, 1 year of 33.8% and 3 years of 4.27%.

First Trust NYSE Arca Biotech ETF have 18.62 avg P/E ratio, also have 5.14 PB ratio. The price to cashflow ratio is 14.9 and the price to sales ratio is 6.15. On 6/23/2006 it begun. Ultragenyx Pharmaceutical Inc is the fund’s main investment for 4.32% of assets, Seattle Genetics Inc for 3.90%, Neurocrine Biosciences Inc for 3.88%, FibroGen Inc for 3.72%, Biogen Inc for 3.58%, Illumina Inc for 3.56%, Qiagen NV for 3.54%, Biomarin Pharmaceutical Inc for 3.52%, Agios Pharmaceuticals Inc for 3.46%, Alexion Pharmaceuticals Inc for 3.45%. ETF’s sector weights are: Basic Materials 0.00%, Consumer Cyclical 0.00%, Financial Services 0.00%, Realestate 0.00%, Consumer Defensive 0.00%, Healthcare 100.00%, Utilities 0.00%, Communication Services 0.00%, Energy 0.00%, Industrials 0.00%, Technology 0.00%. Also has yield.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: